摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-2-phenyl-6,7-dihydro-[1,3,4]thiadiazolo[3,2-α][1,3]diazepin-8(5H)-one | 1402423-91-9

中文名称
——
中文别名
——
英文名称
(E)-2-phenyl-6,7-dihydro-[1,3,4]thiadiazolo[3,2-α][1,3]diazepin-8(5H)-one
英文别名
2-phenyl-6,7-dihydro-[1,3,4]thiadiazolo[3,2-a][1,3]diazepin-8(5H)-one;G5-62;(E)-2-phenyl-6,7-dihydro-[1,3,4]thiadiazolo[3,2-a][1,3]diazepin-8(5H)-one;2-Phenyl-6,7-dihydro-[1,3,4]thiadiazolo[3,2-alpha][1,3]diazepin-8(5H)-one;2-phenyl-6,7-dihydro-5H-[1,3,4]thiadiazolo[3,2-a][1,3]diazepin-8-one
(E)-2-phenyl-6,7-dihydro-[1,3,4]thiadiazolo[3,2-α][1,3]diazepin-8(5H)-one化学式
CAS
1402423-91-9
化学式
C12H11N3OS
mdl
——
分子量
245.305
InChiKey
JVSDFZACAGIJEC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    70.3
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    参考文献:
    名称:
    新型短效催眠药HIE-124的噻二唑[3,2- a ] [1,3]二氮杂analogue类似物的合成,生物学评价和分子建模研究
    摘要:
    合成了一系列新的6,7-二氢-[1,3,4]噻二唑[3,2- a ] [1,3]二氮杂analogue类似物,并对其进行了生物学评估。与硫喷妥钠(6)相比,化合物GS-62(33)表现出强大的体内短效催眠活性,其起效时间,睡眠时间和治疗指数分别为6.4±0.2、94.8±5.3分钟,6.62 。维持剂量为6时,化合物33没有显示出任何急性耐受的迹象。同时33增强了6的体内催眠作用等摩尔量(0.06 mmol)的组合分别显示起效和持续时间分别为7.5±1.3、62.5±5.9分钟。这种组合允许使用较低剂量的两种药物,以避免不良的副作用。对接研究揭示了良好的相互作用和与GABA A受体的BDZ结合位点的结合,尤其是与Arg87,Arg149和Thr151氨基酸残基的结合。
    DOI:
    10.1016/j.ejmech.2016.08.038
点击查看最新优质反应信息

文献信息

  • 6,7-DIHYDRO-[1,3,4]THIADIAZOLO-[3,2-a][1,3]DIAZEPIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS HYPNOTIC OR ANESTHETIC AGENT AND METHOD FOR THEIR PREPARATION
    申请人:Hassan Ghada S.
    公开号:US20140088090A1
    公开(公告)日:2014-03-27
    The present invention relates to a compound of formula 1, a pharmaceutical composition containing the compound, a method for its preparation as well as the use of the compound as hypnotic agent or anesthetic agent.
    本发明涉及一种化合物1的药物组成,包含该化合物的药物组成,以及该化合物作为催眠剂或麻醉剂的制备方法和使用。
  • 6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation
    申请人:Hassan Ghada S.
    公开号:US08741893B2
    公开(公告)日:2014-06-03
    The present invention relates to a compound represented by formula 1 or an addition salt thereof, a pharmaceutical composition containing the compound, a method for its preparation as well as the use of the compound as an hypnotic agent or anesthetic agent: wherein each symbol is as defined in the Specification.
    本发明涉及一种由式1表示的化合物或其加成盐,含有该化合物的药物组合物,其制备方法以及将该化合物用作催眠剂或麻醉剂的用途。其中,每个符号如规范中所定义。
  • 6,7-Dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation
    申请人:King Saud University
    公开号:EP2514753B1
    公开(公告)日:2013-08-21
  • [EN] 6,7-DIYDRO-[1,3,4]THIADIAZOLO-[3,2-A][1,3]DIAZEPIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS HYPNOTIC OR ANESTHETIC AGENT AND METHOD FOR THEIR PREPARATION<br/>[FR] DÉRIVÉS DE LA 6,7-DIHYDRO-[1,3,4] THIADIAZOLO-[3,2-A][1,3] DIAZÉPINE ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT EN TANT QU'AGENT HYPNOTIQUE OU ANESTHÉSIQUE ET PROCÉDÉ POUR LEUR PRÉPARATION
    申请人:UNIV KING SAUD
    公开号:WO2012136356A8
    公开(公告)日:2013-01-03
  • US8741893B2
    申请人:——
    公开号:US8741893B2
    公开(公告)日:2014-06-03
查看更多

同类化合物

雷唑巴占 唑美巴占 六氢-2-(硝基亚氨基)-1H-1,3-二氮杂卓 [1,3]恶唑并[3,2-a][1,3]二氮杂卓 7-苯基-3,4-二氢-1H-1,4-二氮杂革-5(2H)-酮 7,8-二氢-1-苯基-6H-吡啶并(3,2,1-jk)(1,4)苯并二氮杂卓-4(3H)-酮 5H-吡咯并[1,2-a][1,4]二氮杂卓 5-甲基-7-苯基-6,7-二氢-1H-1,4-二氮杂-2,3-二甲腈 5-三氟甲基-2,3-二氢-1H-1,4-二氮杂卓 5,7-二苯基-2,3,6,7-四氢-1H-1,4-二氮杂卓 5,7-二甲基-2,3-二氢-1H-[1,4]二氮杂卓高氯酸盐 5,7-二甲基-2,3,5,6-四氢-1H-环戊二烯并[b]吡嗪 4,5,6,7-四氢-1H-1,3-二氮杂卓-2-胺 3,5,7-三苯基-4H-1,2-二氮杂卓 2H-[1,3,5]恶二嗪o[3,2-a][1,3]二氮杂卓 2-甲基硫代-4,5,6,7-四氢-1H-[1,3]二氮杂卓 2-甲基-4,5,6,7-四氢-1H-1,3-二氮杂卓 2,3-二氢-5-甲基-7-三氟甲基-1H-1,4-二氮杂卓 2,3-二氢-5,7-双(三氟甲基)-1H-1,4-二氮杂卓 1-(5-甲氧基-1,4-二氮杂-1-基)乙酮 1,4,5,7,8,9,10,10A-八氢吡啶并[1,2-a][1,4]二氮杂卓 (9ci)-2,3-二氢-N,N-二甲基-1H-1,4-二氮杂卓-6-甲胺 (9ci)-1H-1,2-二氮杂卓-1-羧酸甲酯 (9ci)-1H,3h-噁唑并[3,4-d][1,4]二氮杂卓 (9ci)-1H,3h-噁唑并[3,4-a][1,4]二氮杂卓 8-Phenyl-2,3,6,7-tetrahydro-4H-1,4-diazocin-5-on 1,3-diphenyl-1,2-dihydro-pyridazino[3,4-b]quinoxaline 3-(4-Bromphenyl)-5,6,7,8-tetrahydro-thiazolo<3,2-a>-<1,3>diazepin 2,3-Dihydro-5-methyl-1,4-diazepin 3-Methyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a][1,3]diazepine 2,4,10,12,18,20-hexamethyl-1,5,9,13,17,21-hexaaza-cyclotetracosa-1,3,9,11,17,19-hexaene 2-(2-benzylidene-3-((4-methylbenzylidene)hydrazineylidene)-2,3,6,7,8,9-hexahydro-5H-thiazolo[2,3-b]quinazolin-5-yl)phenol 3,11-diphenyl-1,5,9,13-tetraaza-cyclohexadeca-1,3,9,11-tetraene 7,10-dichloro-4-[4-(1,1-difluoroethyl)phenyl]-5,6-dihydro-4H-pyrrolo[1,2-a][1,4]-benzodiazepine hydrochloride 7-bromo-5,6-dihydro-2,3-dimethylpyrido<2,3-b>pyrazine 7-(3-Chloro-4-fluoro-phenyl)-5-trifluoromethyl-2,3-dihydro-1H-[1,4]diazepine 6,14-diphenyl-1,4,8,12-tetraaza-cyclopentadeca-4,6,12,14-tetraene 6,13-diphenyl-1,4,8,11-tetraaza-cyclotetradeca-4,6,11,13-tetraene 7-(3-Chloro-4-fluoro-phenyl)-5-phenyl-2,3-dihydro-1H-[1,4]diazepine 7-(4-Fluoro-phenyl)-5-methyl-2,3-dihydro-1H-[1,4]diazepine 3-(7-methyl-5-oxo-4,5-dihydro-2H-pyrazolo[1,5-a]pyrimidin-1-yl)-but-2-enenitrile 7-(2-Fluoro-5-methyl-phenyl)-5-methyl-2,3-dihydro-1H-[1,4]diazepine trans-diazido(2,3,9,10-tetramethyl-1,4,8,11-tetra-azacyclotetradeca-1,3,8,10-tetraene)cobalt(III) perchlorate 2,2-dimethyl-2,6,7,8-tetrahydro-3H-pyrrolo[1,2-a]pyrimidin-4-one ethyl 4-acetamidodiazepine-1-carboxylate 5,7-dimethyl-4,5,6,7-tetrahydro-1H-[1,4]diazepine-2,3-dicarbonitrile 1,4,8,11-Tetraazacyclotetradeca-4,6,11,13-tetraene,5,7,12,14-tetramethyl- 5,6,6,7a-tetramethyl-3-phenyl-5,6,7,7a-tetrahydro-pyrazolo[1,5-d][1,2,4]oxadiazole